Form 4 · Filed Mar 9, 2026, 12:00 PM UTC
NAMS/NewAmsterdam Pharma Co N.V.
Kastelein Johannes Jacob Pieter — Chief Scientific Officer
Pro feature
Read the AI thesis behind every Form 4 — only on Pro and Premium
Free accounts see filings 24 hours late and the thesis is hidden until then. Upgrade to read every Form 4 the moment it hits EDGAR, with a Sonnet-4.6 (or Opus-4.7 on flagged buys) thesis attached.
Free
FreeBrowse the last 30 days of insider filings. Weekly digest by email.
- · Last 30 days of filings (list view)
- · Conviction score badge on each filing
- · Insider profiles & edge scores
Pro
$15/moAI thesis on every filing + watchlist email alerts.
- · Full AI thesis on every Form 4 (Sonnet 4.6)
- · Full filing history (no 30-day cap)
- · Unlimited ticker watchlists
Premium
$49/moOpus 4.7 deep theses + SMS alerts + cluster-buy detection.
- · Everything in Pro
- · Opus-grade thesis on flagged buys
- · SMS alerts for highest-conviction filings
Transactions
9 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | M | other | 101,409 | $0 | — | 520,229 |
| Mar 9, 2026 | M | other | 101,409 | — | — | 170,711 |
| Mar 9, 2026 | S | sell | 101,409 | $30 | $3,071,679 | 69,302 |
| Mar 6, 2026 | S | sell | 94,124 | $30 | $2,853,840 | 69,302 |
| Mar 6, 2026 | M | other | 94,124 | $0 | — | 621,638 |
| Mar 6, 2026 | M | other | 94,124 | — | — | 163,426 |
| Mar 5, 2026 | M | other | 104,467 | — | — | 173,769 |
| Mar 5, 2026 | M | other | 104,467 | $0 | — | 715,762 |
| Mar 5, 2026 | S | sell | 104,467 | $30 | $3,165,350 | 69,302 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-099073